PROCF — Sofgen Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Sofgen Pharma SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	4.23	72.1	43	23.8	30.3
Net Total Accounts Receivable
Net Total Receivables	116	141	132	147	103
Total Inventory
Total Other Current Assets
Total Current Assets	185	298	279	276	217
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	114	113	113	138	134
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	360	462	443	472	412
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	240	188	386	402	416
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	615	500	479	472	463
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-255	-37.4	-36.2	0.21	-51.1
Total Liabilities & Shareholders' Equity	360	462	443	472	412
Total Common Shares Outstanding